Your browser doesn't support javascript.
loading
Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects.
Cho, Chang-Keun; Byeon, Ji-Young; Kang, Pureum; Park, Hye-Jung; Ko, Eunvin; Mu, Chou Yen; Jang, Choon-Gon; Lee, Seok-Yong; Lee, Yun Jeong.
Afiliação
  • Cho CK; School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
  • Byeon JY; School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
  • Kang P; School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
  • Park HJ; School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
  • Ko E; School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
  • Mu CY; School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
  • Jang CG; School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
  • Lee SY; School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea. sylee@skku.ac.kr.
  • Lee YJ; College of Pharmacy, Dankook University, Cheonan, 31116, Republic of Korea.
Arch Pharm Res ; 46(2): 111-116, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36564599
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tolperisona Limite: Humans Idioma: En Revista: Arch Pharm Res Ano de publicação: 2023 Tipo de documento: Article País de publicação:
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tolperisona Limite: Humans Idioma: En Revista: Arch Pharm Res Ano de publicação: 2023 Tipo de documento: Article País de publicação: